SCHEMBL10187304

SCHEMBL10187304

Fc1cc(O[C@@H]2CCOC2)ccc1Br

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 1/20 0.43
ACACB O00763 1/20 0.42
HRH3 Q9Y5N1 2/20 0.42
GRM5 P41594 2/20 0.36
LRRK2 Q5S007 2/20 0.36
ERBB2 P04626 1/20 0.36
EPHA2 P29317 1/20 0.36
KDR P35968 1/20 0.36
EPHB4 P54760 1/20 0.36
IDO1 P14902 1/20 0.36
EGFR P00533 2/20 0.36
APP P05067 1/20 0.36
MAPK14 Q16539 1/20 0.36
PDE2A O00408 1/20 0.35
PDE10A Q9Y233 1/20 0.35
SOS1 Q07889 1/20 0.35
GPER1 Q99527 1/20 0.35
PDE4D Q08499 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27249318 1.00 ALK (0.43) ALKACACBHRH3GRM5LRRK2
SCHEMBL2838384 1.00 ALK (0.43) ALKACACBHRH3GRM5LRRK2
SCHEMBL2836322 0.91 APP (0.43) ALKACACBHRH3GRM5APP
SCHEMBL15615752 0.87 KDM1A (0.38) ALKACACBHRH3GRM5KDR
SCHEMBL9966845 0.82 PTGS1 (0.43) ACACBHRH3KDREGFR
SCHEMBL17669399 0.82 ALK (0.45) ALKHRH3GRM5LRRK2ERBB2
SCHEMBL17282339 0.82 ACACB (0.44) ALKACACBHRH3GRM5LRRK2
SCHEMBL29130936 0.79 ERBB2 (0.46) ALKERBB2EPHA2KDREPHB4
SCHEMBL15573964 0.79 TYR (0.38) GRM5
SCHEMBL18410056 0.79 ERBB2 (0.46) ALKERBB2EPHA2KDREPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2588451-B1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INT (DE) 2015-12-30 EP disclosed
US-9006450-B2 Compounds, pharmaceutical compositions and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2015-04-14 US disclosed
WO-2012001107-A1 PIPERIDINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-01-05 WO disclosed